Unraveling the regulation of mTORC2 using logical modeling

BackgroundThe mammalian target of rapamycin (mTOR) is a regulator of cell proliferation, cell growth and apoptosis working through two distinct complexes: mTORC1 and mTORC2. Although much is known about the activation and inactivation of mTORC1, the processes controlling mTORC2 remain poorly characterized. Experimental and modeling studies have attempted to explain the regulation of mTORC2 but have yielded several conflicting hypotheses. More specifically, the Phosphoinositide 3-kinase (PI3K) pathway was shown to be involved in this process, but the identity of the kinase interacting with and regulating mTORC2 remains to be determined (Cybulski and Hall, Trends Biochem Sci 34:620-7, 2009).MethodWe performed a literature search and identified 5 published hypotheses describing mTORC2 regulation. Based on these hypotheses, we built logical models, not only for each single hypothesis but also for all combinations and possible mechanisms among them. Based on data provided by the original studies, a systematic analysis of all models was performed.ResultsWe were able to find models that account for experimental observations from every original study, but do not require all 5 hypotheses to be implemented. Surprisingly, all hypotheses were in agreement with all tested data gathered from the different studies and PI3K was identified as an essential regulator of mTORC2.ConclusionThe results and additional data suggest that more than one regulator is necessary to explain the behavior of mTORC2. Finally, this study proposes a new experiment to validate mTORC1 as second essential regulator.

[1]  Steven P. Gygi,et al.  Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis , 2013, Nature Cell Biology.

[2]  B. Manning.  Comment on “A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation”: Building a Model of the mTOR Signaling Network with a Potentially Faulty Tool , 2012, Science Signaling.

[3]  Joseph Avruch,et al.  Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.

[4]  Rui-Sheng Wang,et al.  Boolean modeling in systems biology: an overview of methodology and applications , 2012, Physical biology.

[5]  René Thomas.  Regulatory networks seen as asynchronous automata: A logical description , 1991 .

[6]  S. Chandarlapaty,et al.  Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. , 2014, Cancer discovery.

[7]  John McGee,et al.  Discretization of Time Series Data , 2005, J. Comput. Biol..

[8]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[9]  J. Engelman,et al.  The PI3K pathway as drug target in human cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Loewith,et al.  TORC2 Structure and Function. , 2016, Trends in biochemical sciences.

[11]  Nahum Sonenberg,et al.  Dissecting the role of mTOR: lessons from mTOR inhibitors. , 2010, Biochimica et biophysica acta.

[12]  Alessandro Bertuzzi,et al.  Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis , 2016, PloS one.

[13]  D. Fingar,et al.  mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action* , 2009, The Journal of Biological Chemistry.

[14]  Satoru Miyano,et al.  Computational gene network analysis reveals TNF-induced angiogenesis , 2012, BMC Systems Biology.

[15]  Y. Le Marchand-Brustel,et al.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. , 2005, Biochimie.

[16]  A. Beck‐Sickinger,et al.  Cell Communication and Signaling , 2009 .

[17]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[18]  Dianqing Wu,et al.  Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate* , 2011, The Journal of Biological Chemistry.

[19]  C. Proud,et al.  Signaling crosstalk between the mTOR complexes , 2014, Translation.

[20]  K. Guan,et al.  The SIN1-PH Domain Connects mTORC2 to PI3K. , 2015, Cancer discovery.

[21]  Martin Gebser,et al.  Learning Boolean logic models of signaling networks with ASP , 2015, Theor. Comput. Sci..

[22]  A. Sonntag,et al.  A modelling–experimental approach reveals insulin receptor substrate (IRS)‐dependent regulation of adenosine monosphosphate‐dependent kinase (AMPK) by insulin , 2012, The FEBS journal.

[23]  David E James,et al.  A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. , 2015, Cell reports.

[24]  A. Sonntag,et al.  A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation , 2012, Science Signaling.

[25]  Steffen Klamt,et al.  The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data , 2009, PLoS Comput. Biol..

[26]  Kirsten Thobe,et al.  Analysing Cell Line Specific EGFR Signalling via Optimized Automata Based Model Checking , 2015, CMSB.

[27]  Laurence Calzone,et al.  Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Computational Biology.

[28]  D. Fingar,et al.  Growing knowledge of the mTOR signaling network. , 2014, Seminars in cell & developmental biology.

[29]  L. Toral-Barza,et al.  mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer , 2016, Oncotarget.

[30]  Denis Thieffry,et al.  Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Comput. Biol..

[31]  Gerard Manning,et al.  TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. , 2009, Cancer research.

[32]  A. Sonntag,et al.  Response to Comment on “A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation”: Building a Model of the mTOR Signaling Network with a Potentially Faulty Tool , 2012, Science Signaling.

[33]  Julio Saez-Rodriguez,et al.  CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms , 2012, BMC Systems Biology.

[34]  B. Manning,et al.  The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.

[35]  David E. James,et al.  Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2 , 2013, Cell metabolism.

[36]  Erika Ilagan,et al.  Emerging role of mTOR in the response to cancer therapeutics. , 2016, Trends in cancer.

[37]  Sarat Chandarlapaty,et al.  mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. , 2011, Cancer discovery.

[38]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[39]  Kirsten Thobe,et al.  Model Integration and Crosstalk Analysis of Logical Regulatory Networks , 2014, CMSB.

[40]  David Safránek,et al.  Parameter Identification and Model Ranking of Thomas Networks , 2012, CMSB.

[41]  Nadine Cybulski,et al.  TOR complex 2: a signaling pathway of its own. , 2009, Trends in biochemical sciences.

[42]  J. Blenis,et al.  PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex. , 2015, Cancer discovery.

[43]  Hannes Klarner,et al.  Contributions to the Analysis of Qualitative Models of Regulatory Networks , 2015 .